false 0000724004 0000724004 2026-09-08 2026-09-08


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549   
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported): September 8, 2026
 
 
MESA LABORATORIES, INC. 
(Exact name of registrant as specified in its charter)
 
 
Colorado 
(State or other jurisdiction of
incorporation)
0-11740
(Commission File 
Number)
84-0872291 
(I.R.S. Employer
Identification No.)
 
12100 WEST SIXTH AVENUE,
LAKEWOODColorado 
(Address of principal executive offices)
 
80228 

(Zip Code)
 
Registrant’s telephone number, including area code: 303-987-8000
 
Not Applicable  
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered under Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol
 
Name of each exchange on which
registered
Common Stock, no par value
 
MLAB
 
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 


 

 
ITEM 5.07          SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
On September 8, 2026, the Company held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,595,869 shares of Mesa’s common stock were entitled to vote, of which 4,872,692 shares were represented in person or by proxy at the Annual Meeting.
 
The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company’s proxy statement for the Annual Meeting, are as follows:
 
Proposal 1 Election of directors
 
Each of John Sullivan, Siddhartha Kadia, Shiraz Ladiwala, Jennifer “Jenny” Alltoft, Mark Capone, Shannon Hall, and R. Tony Tripeny was elected to the Board of Directors of Mesa to hold office for a one-year term, until the 2027 annual meeting of shareholders:
 
For
Withheld
Broker
Non-Votes
John Sullivan, Ph.D.
4,388,976
145,521
338,195
Siddhartha Kadia, Ph.D.
4,421,045
113,452
338,195
Shiraz Ladiwala
4,402,912
131,585
338,195
Jenny Alltoft
4,395,928
138,569
338,195
Mark Capone
4,405,110
129,387
338,195
Shannon Hall
4,399,078
135,419
338,195
R. Tony Tripeny
4,352,734
181,763
338,195
 
 
Proposal 2 Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Companys independent registered public accounting firm for the fiscal year ending March 31, 2027
 
The appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027 was approved:
 
For
 
Against
 
Abstain
 
Broker 
Non-Votes
4,814,383
 
56,778
 
1,531
 
-
 
 
Proposal 3 Approval on a non-binding basis of the compensation of the Company's named executive officers
 
The compensation of the Company’s named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis:
 
For
 
Against
 
Abstain
 
Broker 
Non-Votes
4,317,389
 
136,782
 
80,326
 
338,195
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
DATE: September 8, 2026
 
Mesa Laboratories, Inc.
 
 
(Registrant)
 
 
 
 
 
 
 
BY: 
/s/ John Sakys  
 
 
John Sakys
 
 
Chief Financial Officer
 

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

IDEA: R1.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: mlab20260901_8k_htm.xml